Necitumumab for first-line treatment of advanced, squamous, non-small-cell lung cancer: a relevant step forward?
Transl Lung Cancer Res
.
2016 Feb;5(1):95-7.
doi: 10.3978/j.issn.2218-6751.2015.08.05.
Authors
Jon Zugazagoitia
1
,
Santiago Ponce
1
,
Luis Paz-Ares
1
Affiliation
1
Medical Oncology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain.
PMID:
26958500
PMCID:
PMC4758970
DOI:
10.3978/j.issn.2218-6751.2015.08.05
No abstract available